New Zealand markets closed

GRAIL, LLC (GRALV)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
18.63+1.41 (+8.19%)
At close: 04:00PM EDT

GRAIL, LLC

1525 O’Brien Drive
Menlo Park, CA 94025
United States
833-694-2553
https://grail.com

Sector(s)Healthcare
IndustryDiagnostics & Research
Full-time employees

Key executives

NameTitlePayExercisedYear born
Mr. Robert P. RagusaChief Executive Officer1.48MN/A1960
Dr. Joshua J. Ofman M.D., M.S.H.SPresident1.04MN/A1965
Mr. Aaron FreidinChief Financial Officer801.32kN/AN/A
Mr. Paul CiccolellaSenior VP of Global Development & OperationsN/AN/AN/A
Ms. Amoolya Singh Ph.D.Senior VP of Research & Chief Scientific OfficerN/AN/AN/A
Mr. Abram Barth J.D., M.P.H.General CounselN/AN/AN/A
Ms. Julie CurrieChief People OfficerN/AN/AN/A
Mr. Rodger CurrieVP and Head of Government Affairs & Alliance DevelopmentN/AN/AN/A
Mr. Gautam K. KolluChief Commercial OfficerN/AN/A1974
Sir Harpal S. Kumar M.A., M.B.A., MA, MBA, MEngPresident Biopharma Business & EuropeN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

GRAIL, LLC, a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. GRAIL, LLC was formerly known as PSC15, Inc. and changed its name to GRAIL, LLC in January 2016. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, LLC operates as a subsidiary of Illumina, Inc.

Corporate governance

GRAIL, LLC’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.